IRIS
PANICHELLA, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.343
NA - Nord America 3.184
EU - Europa 3.085
SA - Sud America 756
AF - Africa 96
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.983
SG - Singapore 1.307
IT - Italia 1.104
CN - Cina 875
RU - Federazione Russa 859
BR - Brasile 588
VN - Vietnam 453
HK - Hong Kong 204
GB - Regno Unito 165
IE - Irlanda 159
DE - Germania 157
NL - Olanda 154
FR - Francia 116
CA - Canada 114
FI - Finlandia 111
IN - India 81
TR - Turchia 74
PL - Polonia 64
AR - Argentina 63
BD - Bangladesh 63
MX - Messico 62
PK - Pakistan 46
IQ - Iraq 36
EC - Ecuador 34
ES - Italia 34
ZA - Sudafrica 34
ID - Indonesia 33
IL - Israele 32
SE - Svezia 30
JP - Giappone 29
AT - Austria 27
CO - Colombia 24
UZ - Uzbekistan 21
UA - Ucraina 19
MA - Marocco 17
CH - Svizzera 15
EG - Egitto 14
CL - Cile 12
LT - Lituania 12
VE - Venezuela 12
PH - Filippine 11
AE - Emirati Arabi Uniti 10
BE - Belgio 10
SA - Arabia Saudita 10
RO - Romania 9
KE - Kenya 8
PY - Paraguay 8
PE - Perù 7
TN - Tunisia 7
AU - Australia 6
MY - Malesia 6
DZ - Algeria 5
HN - Honduras 5
JO - Giordania 5
KR - Corea 5
KZ - Kazakistan 5
OM - Oman 5
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CG - Congo 3
CZ - Repubblica Ceca 3
KW - Kuwait 3
NI - Nicaragua 3
NP - Nepal 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
GT - Guatemala 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AD - Andorra 1
BH - Bahrain 1
CU - Cuba 1
CV - Capo Verde 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
Totale 10.456
Salva come PNG Salva come JPEG
Città #
Dallas 815
Singapore 734
Ashburn 361
San Jose 342
Beijing 321
Hong Kong 194
Moscow 159
Dublin 156
Ho Chi Minh City 152
Los Angeles 124
Hanoi 100
Milan 100
New York 82
Helsinki 74
Rome 73
São Paulo 65
The Dalles 65
Pisa 64
Santa Clara 62
Chandler 60
Hefei 54
Lauterbourg 54
Warsaw 54
Munich 52
Istanbul 47
Council Bluffs 43
Florence 41
Montreal 41
Orem 39
Amsterdam 37
London 37
Da Nang 34
Frankfurt am Main 32
Mexico City 32
Boardman 31
Beauharnois 29
Chicago 29
Genoa 29
Lucca 27
Tokyo 27
Bologna 26
Poplar 26
Rio de Janeiro 26
Brooklyn 25
Naples 25
Stockholm 25
Tel Aviv 25
Boston 24
Lappeenranta 24
Johannesburg 23
Nuremberg 23
Chennai 22
Atlanta 21
Denver 20
Livorno 19
Brescia 18
Buffalo 18
Tashkent 17
Turin 17
Mumbai 16
Belo Horizonte 15
Haiphong 15
Lahore 15
Toronto 15
Guayaquil 14
Manchester 14
Seattle 14
Biên Hòa 13
Phoenix 13
Shenzhen 13
Washington 13
Assago 12
Curitiba 12
Paris 12
Quito 12
Turku 12
Dhaka 11
Querétaro 11
Redondo Beach 11
Baghdad 10
Cambridge 10
Charlotte 10
Guangzhou 10
Houston 10
San Mateo 10
Vienna 10
Bari 9
Brasília 9
Palermo 9
Portsmouth 9
Zhengzhou 9
Ankara 8
Buti 8
City of London 8
Ottawa 8
Porto Alegre 8
San Francisco 8
Zurich 8
Campinas 7
Cascina 7
Totale 5.744
Salva come PNG Salva come JPEG
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 552
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 389
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 310
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 298
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 269
Screening the health status of people working in a university 266
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 254
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 254
Eligibility for vericiguat in a real‐world, contemporary heart failure population 237
RNA-targeting and gene editing therapies for transthyretin amyloidosis 236
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 230
Role of Imaging in Cardiomyopathies 226
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 218
Valvular heart disease in patients with cardiac amyloidosis 205
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 204
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 203
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 201
Subclinical cardiac damage in cancer patients before chemotherapy 201
Cardiac Amyloidosis: How Its Epidemiology is Changing 193
Assessing cardiac mechanics through left ventricular haemodynamic forces 193
The triglyceride/HDL cholesterol ratio and TyG index predict coronary atherosclerosis and outcome in the general population 192
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 190
Sex-related differences in ventricular remodeling after myocardial infarction 189
Bridging Atrial and Ventricular Failure Through Biomarkers 189
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 185
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 180
Sex differences in transthyretin cardiac amyloidosis 178
Current and emerging treatment options for transthyretin amyloid cardiomyopathy 178
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY) 178
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 176
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction 173
Pathophysiology of Cardiac Amyloidosis 171
The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers 171
Pathophysiological Rationale and Clinical Evidence for Neurohormonal Modulation in Heart Failure with Preserved Ejection Fraction 167
Shared and unique characteristics of metabolic syndrome in psychotic disorders: a review 162
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 161
High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis 153
Heart failure with preserved ejection fraction risk after aortic coarctation surgery: The hidden threat 152
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 150
CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis 149
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 148
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 146
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity 139
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 137
Dissecting the heart failure phenotype through phenomics 136
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 122
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 121
Pirfenidone as a novel cardiac protective treatment 120
Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift 117
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 112
Insulin‐like growth factor binding protein‐7 in heart failure: The challenge of moving from risk prediction to a biomarker‐guided management 106
Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow‐up 104
Metabolomics to predict heart failure development: A new frontier? 102
Transesophageal Echocardiography Before Elective Direct Current Cardioversion in Cardiac Amyloidosis: Too Soon to Discard It? 98
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 81
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 54
Transesophageal Echocardiography Before Elective Direct Current Cardioversion in Cardiac Amyloidosis: Too Soon to Discard It? 40
null 29
The evolving role of metabolic and bariatric surgery in contemporary clinical practice 28
PAWP vs LVEDP During Invasive Cardiopulmonary Exercise Testing: In Search of the Holy Grail of a Hemodynamic Truth in Heart Failure. 16
Totale 10.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202266 0 0 0 5 7 7 10 17 7 6 2 5
2022/2023367 5 28 10 21 44 40 14 47 109 10 27 12
2023/2024333 13 11 63 36 7 25 27 13 15 26 28 69
2024/20252.806 71 68 134 108 184 154 383 539 286 175 378 326
2025/20266.967 441 1.077 771 1.145 801 561 747 477 549 398 0 0
Totale 10.539